{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:10:41Z","timestamp":1793833841410,"version":"4.6.1"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"JDS Therapeutics"},{"DOI":"10.13039\/501100004412","name":"T\u00fcrkiye Bilimler Akademisi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004412","id-type":"DOI","asserted-by":"publisher"}]},{"name":"F\u0131rat University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Demyelination is commonly observed in neurodegenerative disorders, including multiple sclerosis (MS). Biotin supplementation is known to stabilize MS progression. To reduce the effective dose of biotin, we synthesized a new and superior form of biotin, a complex of magnesium ionically bound to biotin (MgB) and compared its dose-dependent effect with biotin alone after inducing demyelination using lysolecithin (LPC) in rats. Myelination was assessed using luxol fast blue staining and immunostaining against MBP protein, revealing that the most significant remyelination occurred in the MgB groups. Additionally, both biotin and MgB-treated animals showed dose-dependent improvements in spatial memory. Moreover, we detected a decrease in inflammatory proteins in both treatment groups, which was more prominent in high-dose MgB-treated animals and correlated with decreased expression of NF-\u03baB p65, OP, and MMP-9 proteins. Further analysis of biotin-related proteins demonstrated that both biotin and, notably, MgB reversed the demyelination-dependent reduction of these proteins. Furthermore, biotin, particularly MgB, improved neuronal transmission proteins, Synapsin-1, PSD-93, and PSD-95. Additionally, both treatment groups exhibited increased BDNF, GAP43, and ICAM levels, with significant increments observed in high-dose MgB-treated animals. Increased GFAP, indicative of reactive gliosis, was observed in LPC-treated animals, and this effect was notably reversed by high-dose MgB treatment. The current data emphasize the dose-dependent beneficial effect on the remyelination process. Furthermore, the combination of biotin with Mg resulted in a more potent effect compared to biotin by itself. The strong influence of MgB encourages proof-of-concept studies using MgB in patients with MS.<\/jats:p>","DOI":"10.1007\/s12035-025-04686-y","type":"journal-article","created":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T14:18:30Z","timestamp":1737037110000},"page":"6503-6520","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Dose-Dependent Effect of a New Biotin Compound in Hippocampal Remyelination in Rats"],"prefix":"10.1007","volume":"62","author":[{"given":"Burak","family":"Yulug","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ertugrul","family":"Kilic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuba","family":"O\u011fuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cemal","family":"Orhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Besir","family":"Er","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Tuzcu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim Hanifi","family":"Ozercan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurhan","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinan","family":"Canpolat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Komorowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Perez","family":"Ojalvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Sylla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyda","family":"Cankaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9542-5244","authenticated-orcid":false,"given":"Kazim","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,16]]},"reference":[{"key":"4686_CR1","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.neuropharm.2015.08.028","volume":"110","author":"F Sedel","year":"2016","unstructured":"Sedel F, Bernard D, Mock DM, Tourbah A (2016) Targeting demyelination and virtual hypoxia with high-dose biotin as a treatment for progressive multiple sclerosis. Neuropharmacology 110:644\u2013653. https:\/\/doi.org\/10.1016\/j.neuropharm.2015.08.028","journal-title":"Neuropharmacology"},{"key":"4686_CR2","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.msard.2015.01.005","volume":"4","author":"F Sedel","year":"2015","unstructured":"Sedel F, Papeix C, Bellanger A, Touitou V, Lebrun-Frenay C, Galanaud D, Gout O, Lyon-Caen O et al (2015) High doses of biotin in chronic progressive multiple sclerosis: a pilot study. Mult Scler Relat Disord 4:159\u2013169. https:\/\/doi.org\/10.1016\/j.msard.2015.01.005","journal-title":"Mult Scler Relat Disord"},{"key":"4686_CR3","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1177\/1352458516643396","volume":"22","author":"SK Ludwin","year":"2016","unstructured":"Ludwin SK, Rao VT, Moore CS, Antel JP (2016) Astrocytes in multiple sclerosis. Mult Scler J 22:1114\u20131124. https:\/\/doi.org\/10.1177\/1352458516643396","journal-title":"Mult Scler J"},{"key":"4686_CR4","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.bbadis.2010.07.007","volume":"1812","author":"C Stadelmann","year":"2011","unstructured":"Stadelmann C, Wegner C, Br\u00fcck W (2011) Inflammation, demyelination, and degeneration - recent insights from MS pathology. Biochim Biophys Acta-Mol Basis Dis 1812:275\u2013282. https:\/\/doi.org\/10.1016\/j.bbadis.2010.07.007","journal-title":"Biochim Biophys Acta-Mol Basis Dis"},{"key":"4686_CR5","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.neuint.2003.08.018","volume":"45","author":"MM Ayers","year":"2004","unstructured":"Ayers MM, Hazelwood LJ, Catmull DV, Wang D, McKormack Q, Bernard CC, Orian JM (2004) Early glial responses in murine models of multiple sclerosis. Neurochem Int 45:409\u2013419. https:\/\/doi.org\/10.1016\/j.neuint.2003.08.018","journal-title":"Neurochem Int"},{"key":"4686_CR6","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2174\/1573406413666170906122803","volume":"14","author":"M Boziki","year":"2018","unstructured":"Boziki M, Grigoriadis N (2018) An update on the role of matrix metalloproteinases in the pathogenesis of multiple sclerosis. Med Chem 14:155\u2013169. https:\/\/doi.org\/10.2174\/1573406413666170906122803","journal-title":"Med Chem"},{"key":"4686_CR7","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1600-0404.2006.00749.x","volume":"115","author":"A Szczuci\u0144ski","year":"2007","unstructured":"Szczuci\u0144ski A, Losy J (2007) Chemokines and chemokine receptors in multiple sclerosis. Potential targets for new therapies. Acta Neurol Scand 115:137\u2013146. https:\/\/doi.org\/10.1111\/j.1600-0404.2006.00749.x","journal-title":"Acta Neurol Scand"},{"key":"4686_CR8","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/j.immuni.2015.10.017","volume":"43","author":"MM Guerrini","year":"2015","unstructured":"Guerrini MM, Okamoto K, Komatsu N, Sawa S, Danks L, Penninger JM, Nakashima T, Takayanagi H (2015) Inhibition of the TNF family cytokine RANKL prevents autoimmune inflammation in the central nervous system. Immunity 43:1174\u20131185. https:\/\/doi.org\/10.1016\/j.immuni.2015.10.017","journal-title":"Immunity"},{"key":"4686_CR9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1159\/000488988","volume":"25","author":"A Glasnovi\u0107","year":"2018","unstructured":"Glasnovi\u0107 A, Stoji\u0107 M, De\u017emalj L, Tudori\u0107-\u0110eno I, Romi\u0107 D, Jele\u010d V, Vrca A, Vuleti\u0107 V et al (2018) RANKL\/RANK\/OPG axis is deregulated in the cerebrospinal fluid of multiple sclerosis patients at clinical onset. NeuroImmunoModulation 25:23\u201333. https:\/\/doi.org\/10.1159\/000488988","journal-title":"NeuroImmunoModulation"},{"key":"4686_CR10","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.4049\/jimmunol.0802954","volume":"182","author":"R Brambilla","year":"2009","unstructured":"Brambilla R, Persaud T, Hu X, Karmally S, Shestopalov VI, Dvoriantchikova G, Ivanov D, Nathanson L et al (2009) Transgenic inhibition of astroglial NF-\u03baB improves functional outcome in experimental autoimmune encephalomyelitis by suppressing chronic central nervous system inflammation. J Immunol 182:2628\u20132640. https:\/\/doi.org\/10.4049\/jimmunol.0802954","journal-title":"J Immunol"},{"key":"4686_CR11","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1177\/1352458506070605","volume":"12","author":"B Weinstock-Guttman","year":"2006","unstructured":"Weinstock-Guttman B, Hong J, Santos R, Tama\u00f1o-Blanco M, Badgett D, Patrick K, Baier M, Feichter J et al (2006) Interferon-\u03b2 modulates bone-associated cytokines and osteoclast precursor activity in multiple sclerosis patients. Mult Scler J 12:541\u2013550. https:\/\/doi.org\/10.1177\/1352458506070605","journal-title":"Mult Scler J"},{"key":"4686_CR12","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.5114\/aoms.2015.56342","volume":"6","author":"S Bathina","year":"2015","unstructured":"Bathina S, Das UN (2015) Brain-derived neurotrophic factor and its clinical implications. Arch Med Sci 6:1164\u20131178. https:\/\/doi.org\/10.5114\/aoms.2015.56342","journal-title":"Arch Med Sci"},{"key":"4686_CR13","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1083\/jcb.200601087","volume":"174","author":"SX Bamji","year":"2006","unstructured":"Bamji SX, Rico B, Kimes N, Reichardt LF (2006) BDNF mobilizes synaptic vesicles and enhances synapse formation by disrupting cadherin\u2013\u03b2-catenin interactions. J Cell Biol 174:289\u2013299. https:\/\/doi.org\/10.1083\/jcb.200601087","journal-title":"J Cell Biol"},{"key":"4686_CR14","doi-asserted-by":"publisher","first-page":"7088","DOI":"10.1523\/JNEUROSCI.0487-18.2018","volume":"38","author":"JL Fletcher","year":"2018","unstructured":"Fletcher JL, Wood RJ, Nguyen J, Norman EML, Jun CMK, Prawdiuk AR, Biemond M, Nguyen HTH et al (2018) Targeting TrkB with a brain-derived neurotrophic factor mimetic promotes myelin repair in the brain. J Neurosci 38:7088\u20137099. https:\/\/doi.org\/10.1523\/JNEUROSCI.0487-18.2018","journal-title":"J Neurosci"},{"key":"4686_CR15","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3389\/fimmu.2018.00217","volume":"9","author":"G Ponath","year":"2018","unstructured":"Ponath G, Park C, Pitt D (2018) The role of astrocytes in multiple sclerosis. Front Immunol 9:217. https:\/\/doi.org\/10.3389\/fimmu.2018.00217","journal-title":"Front Immunol"},{"key":"4686_CR16","doi-asserted-by":"publisher","first-page":"486","DOI":"10.3389\/fphys.2019.00486","volume":"10","author":"S P\u00f6yh\u00f6nen","year":"2019","unstructured":"P\u00f6yh\u00f6nen S, Er S, Domanskyi A, Airavaara M (2019) Effects of neurotrophic factors in glial cells in the central nervous system: expression and properties in neurodegeneration and injury. Front Physiol 10:486. https:\/\/doi.org\/10.3389\/fphys.2019.00486","journal-title":"Front Physiol"},{"key":"4686_CR17","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12974-017-0930-6","volume":"14","author":"D Xu","year":"2017","unstructured":"Xu D, Lian D, Wu J, Liu Y, Zhu M, Sun J, He D, Li L (2017) Brain-derived neurotrophic factor reduces inflammation and hippocampal apoptosis in experimental Streptococcus pneumoniae meningitis. J Neuroinflammation 14:156. https:\/\/doi.org\/10.1186\/s12974-017-0930-6","journal-title":"J Neuroinflammation"},{"key":"4686_CR18","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1046\/j.1365-3083.2003.01260.x","volume":"57","author":"A Gielen","year":"2003","unstructured":"Gielen A, Khademi M, Muhallab S, Olsson T, Piehl F (2003) Increased brain-derived neurotrophic factor expression in white blood cells of relapsing-remitting multiple sclerosis patients. Scand J Immunol 57:493\u2013497. https:\/\/doi.org\/10.1046\/j.1365-3083.2003.01260.x","journal-title":"Scand J Immunol"},{"key":"4686_CR19","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1093\/brain\/awf015","volume":"125","author":"C Stadelmann","year":"2002","unstructured":"Stadelmann C, Kerschensteiner M, Misgeld T, Br\u00fcck W, Hohlfeld R, Lassmann H (2002) BDNF and gp145trkB in multiple sclerosis brain lesions: neuroprotective interactions between immune and neuronal cells? Brain 125:75\u201385. https:\/\/doi.org\/10.1093\/brain\/awf015","journal-title":"Brain"},{"key":"4686_CR20","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.yfrne.2006.09.003","volume":"27","author":"F Sohrabji","year":"2006","unstructured":"Sohrabji F, Lewis DK (2006) Estrogen\u2013BDNF interactions: Implications for neurodegenerative diseases. Front Neuroendocrinol 27:404\u2013414. https:\/\/doi.org\/10.1016\/j.yfrne.2006.09.003","journal-title":"Front Neuroendocrinol"},{"key":"4686_CR21","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1590\/S0004-282X2011000400024","volume":"69","author":"A Mendes","year":"2011","unstructured":"Mendes A, S\u00e1 MJ (2011) Classical immunomodulatory therapy in multiple sclerosis: how it acts, how it works. Arq Neuropsiquiatr 69:536\u2013543. https:\/\/doi.org\/10.1590\/S0004-282X2011000400024","journal-title":"Arq Neuropsiquiatr"},{"key":"4686_CR22","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.15252\/embj.201695810","volume":"36","author":"S Camandola","year":"2017","unstructured":"Camandola S, Mattson MP (2017) Brain metabolism in health, aging, and neurodegeneration. EMBO J 36:1474\u20131492. https:\/\/doi.org\/10.15252\/embj.201695810","journal-title":"EMBO J"},{"key":"4686_CR23","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1177\/1352458516667568","volume":"22","author":"A Tourbah","year":"2016","unstructured":"Tourbah A, Lebrun-Frenay C, Edan G, Clanet M, Papeix C, Vukusic S, De S\u00e8ze J, Debouverie M et al (2016) MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: a randomized, double-blind, placebo-controlled study. Mult Scler J 22:1719\u20131731. https:\/\/doi.org\/10.1177\/1352458516667568","journal-title":"Mult Scler J"},{"key":"4686_CR24","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.msard.2017.09.030","volume":"18","author":"G Birnbaum","year":"2017","unstructured":"Birnbaum G, Stulc J (2017) High dose biotin as treatment for progressive multiple sclerosis. Mult Scler Relat Disord 18:141\u2013143. https:\/\/doi.org\/10.1016\/j.msard.2017.09.030","journal-title":"Mult Scler Relat Disord"},{"key":"4686_CR25","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s40263-018-0528-2","volume":"32","author":"A Tourbah","year":"2018","unstructured":"Tourbah A, Gout O, Vighetto A, Deburghgraeve V, Pelletier J, Papeix C, Lebrun-Frenay C, Labauge P et al (2018) MD1003 (high-dose pharmaceutical-grade biotin) for the treatment of chronic visual loss related to optic neuritis in multiple sclerosis: a randomized, double-blind, placebo-controlled study. CNS Drugs 32:661\u2013672. https:\/\/doi.org\/10.1007\/s40263-018-0528-2","journal-title":"CNS Drugs"},{"key":"4686_CR26","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s00018-012-1096-0","volume":"70","author":"L Tong","year":"2013","unstructured":"Tong L (2013) Structure and function of biotin-dependent carboxylases. Cell Mol Life Sci 70:863\u2013891. https:\/\/doi.org\/10.1007\/s00018-012-1096-0","journal-title":"Cell Mol Life Sci"},{"key":"4686_CR27","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s12031-017-1007-9","volume":"64","author":"Y Tai","year":"2018","unstructured":"Tai Y, Qiu Y, Bao Z (2018) Magnesium lithospermate b suppresses lipopolysaccharide-induced neuroinflammation in BV2 microglial cells and attenuates neurodegeneration in lipopolysaccharide-injected mice. J Mol Neurosci 64:80\u201392. https:\/\/doi.org\/10.1007\/s12031-017-1007-9","journal-title":"J Mol Neurosci"},{"key":"4686_CR28","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0306-9877(86)90010-1","volume":"21","author":"P Goldberg","year":"1986","unstructured":"Goldberg P, Fleming MC, Picard EH (1986) Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D. Med Hypotheses 21:193\u2013200. https:\/\/doi.org\/10.1016\/0306-9877(86)90010-1","journal-title":"Med Hypotheses"},{"key":"4686_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7224\/1537-2073.2017-039","volume":"21","author":"L Bromley","year":"2019","unstructured":"Bromley L, Horvath PJ, Bennett SE, Weinstock-Guttman B, Ray AD (2019) Impact of nutritional intake on function in people with mild-to-moderate multiple sclerosis. Int J MS Care 21:1\u20139. https:\/\/doi.org\/10.7224\/1537-2073.2017-039","journal-title":"Int J MS Care"},{"key":"4686_CR30","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/j.1600-0404.1990.tb00965.x","volume":"81","author":"M Yasui","year":"1990","unstructured":"Yasui M, Yase Y, Ando K, Adachi K, Mukoyama M, Ohsugi K (1990) Magnesium concentration in brains from multiple sclerosis patients. Acta Neurol Scand 81:197\u2013200. https:\/\/doi.org\/10.1111\/j.1600-0404.1990.tb00965.x","journal-title":"Acta Neurol Scand"},{"key":"4686_CR31","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1111\/j.1600-0404.1999.tb07369.x","volume":"99","author":"M Anagnostouli","year":"1999","unstructured":"Anagnostouli M, Livaniou E, Nyalala JO, Evangelatos G, Zournas C, Ithakissios DS, Papageorgiou C (1999) Cerebrospinal fluid levels of biotin in various neurological disorders. Acta Neurol Scand 99:387\u2013392. https:\/\/doi.org\/10.1111\/j.1600-0404.1999.tb07369.x","journal-title":"Acta Neurol Scand"},{"key":"4686_CR32","first-page":"314","volume":"17","author":"J Durlach","year":"2004","unstructured":"Durlach J, Pag\u00e8s N, Bac P, Bara M, Guiet-Bara A (2004) Importance of magnesium depletion with hypofunction of the biological clock in the pathophysiology of headhaches with photophobia, sudden infant death and some clinical forms of multiple sclerosis. Magnes Res 17:314\u2013326 (PMID: 15726907)","journal-title":"Magnes Res"},{"key":"4686_CR33","doi-asserted-by":"crossref","first-page":"P5.348","DOI":"10.1212\/WNL.90.15_supplement.P5.348","volume":"90","author":"P Branger","year":"2018","unstructured":"Branger P, Derache N, Kassis N, Maillart E, Assouad R, Deffer G (2018) Relapses during high doses of biotin in progressive multiple sclerosis: a case series (P5.348). Neurology 90:P5.348","journal-title":"Neurology"},{"key":"4686_CR34","doi-asserted-by":"publisher","unstructured":"Ojalvo SP, Sylla S, Komorowski J (2019) Pharmacokinetics of a novel form of biotin, magnesium biotinate, in healthy subjects (P06\u2013027\u201319). Curr Dev Nutr 3 (Suppl 1):nzz031.P06\u2013027\u201319. https:\/\/doi.org\/10.1093\/cdn\/nzz031.P06-027-19","DOI":"10.1093\/cdn\/nzz031.P06-027-19"},{"key":"4686_CR35","first-page":"1","volume":"31","author":"JW Shin","year":"2010","unstructured":"Shin JW, Seol IC, Son CG (2010) Interpretation of animal dose and human equivalent dose for drug development. J Korean Med 31:1\u20137","journal-title":"J Korean Med"},{"key":"4686_CR36","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/0976-0105.177703","volume":"7","author":"A Nair","year":"2016","unstructured":"Nair A, Jacob S (2016) A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm 7:27. https:\/\/doi.org\/10.4103\/0976-0105.177703","journal-title":"J Basic Clin Pharm"},{"key":"4686_CR37","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.bbr.2017.08.046","volume":"336","author":"A Mousavi Majd","year":"2018","unstructured":"Mousavi Majd A, Ebrahim Tabar F, Afghani A, Ashrafpour S, Dehghan S, Gol M, Ashrafpour M, Pourabdolhossein F (2018) Inhibition of GABA A receptor improved special memory impairment in the local model of demyelination in rat hippocampus. Behav Brain Res 336:111\u2013121. https:\/\/doi.org\/10.1016\/j.bbr.2017.08.046","journal-title":"Behav Brain Res"},{"key":"4686_CR38","doi-asserted-by":"publisher","first-page":"332","DOI":"10.4103\/1673-5374.265565","volume":"15","author":"NW Zhu","year":"2020","unstructured":"Zhu NW, Yin XL, Lin R, Fan XL, Chen SJ, Zhu YM, Zhao XZ (2020) Possible mechanisms of lycopene amelioration of learning and memory impairment in rats with vascular dementia. Neural Regen Res 15:332\u2013341. https:\/\/doi.org\/10.4103\/1673-5374.265565","journal-title":"Neural Regen Res"},{"key":"4686_CR39","doi-asserted-by":"publisher","first-page":"657207","DOI":"10.3389\/fphar.2021.657207","volume":"12","author":"D Cicek","year":"2021","unstructured":"Cicek D, Demir B, Orhan C, Tuzcu M, Ozercan IH, Sahin N, Komorowski J, Ojalvo SP et al (2021) The protective effects of a combination of an arginine silicate complex and magnesium biotinate against UV-induced skin damage in rats. Front Pharmacol 12:657207. https:\/\/doi.org\/10.3389\/fphar.2021.657207","journal-title":"Front Pharmacol"},{"key":"4686_CR40","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/s0076-6879(97)79030-x","volume":"279","author":"DM Mock","year":"1997","unstructured":"Mock DM (1997) Determinations of biotin in biological fluids. Methods Enzymol 279:265\u2013275. https:\/\/doi.org\/10.1016\/s0076-6879(97)79030-x","journal-title":"Methods Enzymol"},{"key":"4686_CR41","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1093\/jn\/131.9.2310","volume":"131","author":"B Lewis","year":"2001","unstructured":"Lewis B, Rathman S, McMahon R (2001) Dietary biotin intake modulates the pool of free and protein-bound biotin in rat liver. J Nutr 131:2310\u20132315. https:\/\/doi.org\/10.1093\/jn\/131.9.2310","journal-title":"J Nutr"},{"key":"4686_CR42","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1093\/jn\/133.9.2857","volume":"133","author":"SC Rathman","year":"2003","unstructured":"Rathman SC, Gregory JF, McMahon RJ (2003) Pharmacological biotin supplementation maintains biotin status and function in rats administered dietary carbamazepine. J Nutr 133:2857\u20132862. https:\/\/doi.org\/10.1093\/jn\/133.9.2857","journal-title":"J Nutr"},{"key":"4686_CR43","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s12017-011-8143-0","volume":"13","author":"S Mozafari","year":"2011","unstructured":"Mozafari S, Javan M, Sherafat MA, Mirnajafi-Zadeh J, Heibatollahi M, Pour-Beiranvand S, Tiraihi T, Ahmadiani A (2011) Analysis of structural and molecular events associated with adult rat optic chiasm and nerves demyelination and remyelination; possible role for 3rd ventricle proliferating cells. NeuroMolecular Med 13:138\u2013150. https:\/\/doi.org\/10.1007\/s12017-011-8143-0","journal-title":"NeuroMolecular Med"},{"key":"4686_CR44","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s12011-021-02619-z","volume":"200","author":"C Orhan","year":"2022","unstructured":"Orhan C, Tuzcu M, Deeh Defo PB, Sahin N, Ojalvo SP, Sylla S, Komorowski JR, Sahin K (2022) Effects of a novel magnesium complex on metabolic and cognitive functions and the expression of synapse-associated proteins in rats fed a high-fat diet. Biol Trace Elem Res 200:247\u2013260. https:\/\/doi.org\/10.1007\/s12011-021-02619-z","journal-title":"Biol Trace Elem Res"},{"key":"4686_CR45","doi-asserted-by":"publisher","first-page":"925","DOI":"10.3390\/pharmaceutics13070925","volume":"22","author":"K Alhazzani","year":"2021","unstructured":"Alhazzani K, Ahmad SF, Al-Harbi NO, Attia SM, Bakheet SA, Sarawi W, Alqarni SA, Algahtani M, Nadeem A (2021) Pharmacological inhibition of STAT3 by stattic ameliorates clinical symptoms and reduces autoinflammation in myeloid, lymphoid, and neuronal tissue compartments in relapsing-remitting model of experimental autoimmune encephalomyelitis in SJL\/J mice. Pharmaceutics 22:925. https:\/\/doi.org\/10.3390\/pharmaceutics13070925","journal-title":"Pharmaceutics"},{"key":"4686_CR46","doi-asserted-by":"publisher","first-page":"113997","DOI":"10.1016\/j.expneurol.2022.113997","volume":"351","author":"MA Ansari","year":"2022","unstructured":"Ansari MA, Nadeem A, Alshammari MA, Attia SM, Bakheet SA, Khan MR, Albekairi TH, Alasmari AF et al (2022) Cathepsin B inhibitor alleviates Th1, Th17, and Th22 transcription factor signaling dysregulation in experimental autoimmune encephalomyelitis. Exp Neurol 351:113997. https:\/\/doi.org\/10.1016\/j.expneurol.2022.113997","journal-title":"Exp Neurol"},{"key":"4686_CR47","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.cyto.2017.05.018","volume":"97","author":"A Nadeem","year":"2017","unstructured":"Nadeem A, Ahmad SF, Al-Harbi NO, Fardan AS, El-Sherbeeny AM, Ibrahim KE, Attia SM (2017) IL-17A causes depression-like symptoms via NF\u03baB and p38MAPK signaling pathways in mice: implications for psoriasis associated depression. Cytokine 97:14\u201324. https:\/\/doi.org\/10.1016\/j.cyto.2017.05.018","journal-title":"Cytokine"},{"key":"4686_CR48","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/mp.2016.167","volume":"23","author":"N Kappelmann","year":"2016","unstructured":"Kappelmann N, Lewis G, Dantzer R, Jones PB, Khandaker GM (2016) Antidepressant activity of anti-cytokine treatment: a systematic review and meta-analysis of clinical trials of chronic inflammatory conditions. Mol Psychiatry 23:335\u2013343. https:\/\/doi.org\/10.1038\/mp.2016.167","journal-title":"Mol Psychiatry"},{"key":"4686_CR49","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.jaad.2009.07.022","volume":"62","author":"A Menter","year":"2010","unstructured":"Menter A, Augustin M, Signorovitch J, Yu AP, Wu EQ, Gupta SR, Bao Y, Mulani P (2010) The effect of adalimumab on reducing depression symptoms in patients with moderate to severe psoriasis: a randomized clinical trial. J Am Acad Dermatol 62:812\u2013818. https:\/\/doi.org\/10.1016\/j.jaad.2009.07.022","journal-title":"J Am Acad Dermatol"},{"key":"4686_CR50","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0022-510X(02)00069-2","volume":"206","author":"C Bjartmar","year":"2003","unstructured":"Bjartmar C, Wujek J, Trapp B (2003) Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease. J Neurol Sci 206:165\u2013171. https:\/\/doi.org\/10.1016\/S0022-510X(02)00069-2","journal-title":"J Neurol Sci"},{"key":"4686_CR51","doi-asserted-by":"publisher","first-page":"v10","DOI":"10.1007\/s00415-005-5003-6","volume":"252","author":"W Br\u00fcck","year":"2005","unstructured":"Br\u00fcck W (2005) Inflammatory demyelination is not central to the pathogenesis of multiple sclerosis. J Neurol 252:v10\u2013v15. https:\/\/doi.org\/10.1007\/s00415-005-5003-6","journal-title":"J Neurol"},{"key":"4686_CR52","doi-asserted-by":"publisher","first-page":"439","DOI":"10.2174\/1871527317666180501110918","volume":"17","author":"B Yulug","year":"2018","unstructured":"Yulug B, Kilic E, Altunay S, Ersavas C, Orhan C, Dalay A, Tuzcu M, Sahin N et al (2018) Cinnamon polyphenol extract exerts neuroprotective activity in traumatic brain injury in male mice. CNS neurol disord drug targets 17:439\u2013447. https:\/\/doi.org\/10.2174\/1871527317666180501110918","journal-title":"CNS neurol disord drug targets"},{"key":"4686_CR53","doi-asserted-by":"crossref","first-page":"751687","DOI":"10.3389\/fneur.2021.751687","volume":"12","author":"R Cortese","year":"2021","unstructured":"Cortese R, Carotenuto A, Di Filippo M, Lanzillo R (2021) Cognition in multiple sclerosis. Front Neurol 12:751687","journal-title":"Front Neurol"},{"issue":"10","key":"4686_CR54","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S1474-4422(20)30277-5","volume":"19","author":"RH Benedict","year":"2020","unstructured":"Benedict RH, Amato MP, DeLuca J, Geurts JJ (2020) Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenues. The Lancet Neurology 19(10):860\u2013871","journal-title":"The Lancet Neurology"},{"issue":"11","key":"4686_CR55","doi-asserted-by":"crossref","first-page":"450","DOI":"10.3390\/metabo10110450","volume":"10","author":"JW B\u0142aszczyk","year":"2020","unstructured":"B\u0142aszczyk JW (2020) Energy metabolism decline in the aging brain\u2014pathogenesis of neurodegenerative disorders. Metabolites 10(11):450","journal-title":"Metabolites"},{"key":"4686_CR56","doi-asserted-by":"crossref","unstructured":"Manza, P., Wiers, C. E., Shokri-Kojori, E., Kroll, D., Feldman, D., Schwandt, M., ... & Volkow, N. D. (2020). Brain network segregation and glucose energy utilization: relevance for age-related differences in cognitive function.\u00a0Cerebral Cortex,\u00a030(11), 5930\u20135942.","DOI":"10.1093\/cercor\/bhaa167"},{"key":"4686_CR57","doi-asserted-by":"crossref","unstructured":"Braun, U., Sch\u00e4fer, A., Walter, H., Erk, S., Romanczuk-Seiferth, N., Haddad, L., ... & Bassett, D. S. (2015). Dynamic reconfiguration of frontal brain networks during executive cognition in humans.\u00a0Proceedings of the National Academy of Sciences,\u00a0112(37), 11678\u201311683.","DOI":"10.1073\/pnas.1422487112"},{"key":"4686_CR58","doi-asserted-by":"crossref","unstructured":"Yulug, B., Altay, O., Li, X., Hanoglu, L., Cankaya, S., Lam, S., ... & Mardinoglu, A. (2023). Combined metabolic activators improve cognitive functions in Alzheimer\u2019s disease patients: a randomised, double-blinded, placebo-controlled phase-II trial.\u00a0Translational Neurodegeneration,\u00a012(1), 1\u201323.","DOI":"10.1186\/s40035-023-00336-2"},{"key":"4686_CR59","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1080\/08977190410001723308","volume":"22","author":"DK Binder","year":"2004","unstructured":"Binder DK, Scharfman HE (2004) Brain-derived neurotrophic factor. Growth Factors 22:123\u2013131. https:\/\/doi.org\/10.1080\/08977190410001723308","journal-title":"Growth Factors"},{"key":"4686_CR60","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1254\/jphs.91.267","volume":"91","author":"K Yamada","year":"2003","unstructured":"Yamada K, Nabeshima T (2003) Brain-derived neurotrophic factor\/TrkB signaling in memory processes. J Pharmacol Sci 91:267\u2013270. https:\/\/doi.org\/10.1254\/jphs.91.267","journal-title":"J Pharmacol Sci"},{"key":"4686_CR61","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/331261a0","volume":"331","author":"MM Hofer","year":"1988","unstructured":"Hofer MM, Barde Y-A (1988) Brain-derived neurotrophic factor prevents neuronal death in vivo. Nature 331:261\u2013262. https:\/\/doi.org\/10.1038\/331261a0","journal-title":"Nature"},{"key":"4686_CR62","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.brainresbull.2008.12.002","volume":"78","author":"B Yulug","year":"2009","unstructured":"Yulug B, Ozan E, Gonul AS, Kilic E (2009) Brain-derived neurotrophic factor, stress and depression: a minireview. Brain Res Bull 78:267\u2013269. https:\/\/doi.org\/10.1016\/j.brainresbull.2008.12.002","journal-title":"Brain Res Bull"},{"key":"4686_CR63","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.neuroscience.2009.08.028","volume":"164","author":"D Ballhausen","year":"2009","unstructured":"Ballhausen D, Mittaz L, Boulat O, Bonaf\u00e9 L, Braissant O (2009) Evidence for catabolic pathway of propionate metabolism in CNS: expression pattern of methylmalonyl-CoA mutase and propionyl-CoA carboxylase alpha-subunit in developing and adult rat brain. Neuroscience 164:578\u2013587. https:\/\/doi.org\/10.1016\/j.neuroscience.2009.08.028","journal-title":"Neuroscience"},{"key":"4686_CR64","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/S0169-328X(03)00033-0","volume":"112","author":"G Chakraborty","year":"2003","unstructured":"Chakraborty G, Ledeen R (2003) Fatty acid synthesizing enzymes intrinsic to myelin. Mol Brain Res 112:46\u201352. https:\/\/doi.org\/10.1016\/S0169-328X(03)00033-0","journal-title":"Mol Brain Res"},{"key":"4686_CR65","doi-asserted-by":"publisher","first-page":"625167","DOI":"10.3389\/fnins.2021.625167","volume":"15","author":"K Holikova","year":"2021","unstructured":"Holikova K, Laakso H, Salo R, Shatillo A, Nurmi A, Bares M, Vanicek J, Michaeli S et al (2021) Magnetization transfer and diffusion tensor MRI of lysophosphatidylcholine induced demyelination and remyelination in rats. Front Neurosci 15:625167. https:\/\/doi.org\/10.3389\/fnins.2021.625167","journal-title":"Front Neurosci"},{"key":"4686_CR66","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1097\/00001756-200204160-00018","volume":"13","author":"I Jean","year":"2002","unstructured":"Jean I, Allamargot C, Barthelaix-Pouplard A, Fressinaud C (2002) Axonal lesions and PDGF-enhanced remyelination in the rat corpus callosum after lysolecithin demyelination. NeuroReport 13:627\u2013631. https:\/\/doi.org\/10.1097\/00001756-200204160-00018","journal-title":"NeuroReport"},{"key":"4686_CR67","doi-asserted-by":"crossref","first-page":"5600","DOI":"10.1016\/S0021-9258(18)62697-3","volume":"245","author":"K Dakshinamurti","year":"1970","unstructured":"Dakshinamurti K, Litvak S (1970) Biotin and protein synthesis in rat liver. J Biol Chem 245:5600\u20135605 (PMID: 5472359)","journal-title":"J Biol Chem"},{"key":"4686_CR68","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1097\/01.wco.0000073928.19076.84","volume":"16","author":"JA Bobholz","year":"2003","unstructured":"Bobholz JA, Rao SM (2003) Cognitive dysfunction in multiple sclerosis: a review of recent developments. Curr Opin Neurol 16:283\u2013288. https:\/\/doi.org\/10.1097\/01.wco.0000073928.19076.84","journal-title":"Curr Opin Neurol"},{"key":"4686_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-94-007-2199-9_1","volume":"56","author":"HM Said","year":"2012","unstructured":"Said HM (2012) Biotin: biochemical, physiological and clinical aspects. Subcell Biochem 56:1\u201319. https:\/\/doi.org\/10.1007\/978-94-007-2199-9_1","journal-title":"Subcell Biochem"},{"key":"4686_CR70","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1177\/1352458519894713","volume":"26","author":"L Couloume","year":"2020","unstructured":"Couloume L, Barbin L, Leray E, Wiertlewski S, Le Page E, Kerbrat A, Ory S, Port D et al (2020) High-dose biotin in progressive multiple sclerosis: a prospective study of 178 patients in routine clinical practice. Mult Scler J 26:1898\u20131906. https:\/\/doi.org\/10.1177\/1352458519894713","journal-title":"Mult Scler J"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-04686-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-04686-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-04686-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:05:46Z","timestamp":1743379546000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-04686-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,16]]},"references-count":70,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["4686"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-04686-y","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,16]]},"assertion":[{"value":"24 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study complied with ethical concerns and was approved by the Firat University Animal Research Ethics Committee, Approved number: 257169.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"James Komorowski, Sara Perez Ojalvo, and Sarah Sylla are employed by JDS Therapeutics, LLC (Purchase, NY, USA). The other authors declare no conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}